SCHEMBL13701423

SCHEMBL13701423

COc1ccc(-c2nc(CNC(C)=O)co2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 4/20 0.46
MAPK1 P28482 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALOX15 P16050 1/20 0.46
MAPT P10636 3/20 0.46
TP53 P04637 1/20 0.46
ADORA3 P0DMS8 2/20 0.45
HPGD P15428 4/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
CYP1A2 P05177 1/20 0.44
LMNA P02545 3/20 0.43
PI4KB Q9UBF8 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13701420 0.89 DHODH (0.43) ALDH1A1HSD17B10MAPK1MEN1KMT2A
SCHEMBL15450565 0.88 HPGD (0.40) ALDH1A1HSD17B10MAPK1MEN1KMT2A
SCHEMBL13701421 0.88 PDE4B (0.46) ALDH1A1MAPTHPGDKDM4EGAA
SCHEMBL13701419 0.86 S1PR1 (0.45) ALDH1A1HSD17B10MAPK1MEN1KMT2A
SCHEMBL4271190 0.83 ALDH1A1 (0.48) ALDH1A1HSD17B10MAPK1MEN1KMT2A
SCHEMBL4282801 0.82 HPGD (0.46) ALDH1A1HSD17B10MEN1KMT2AMAPT
SCHEMBL4270541 0.82 KMT2A (0.48) HSD17B10MEN1KMT2AMAPTHPGD
SCHEMBL19194454 0.81 MAPT (0.44) ALDH1A1MAPK1MEN1KMT2AMAPT
SCHEMBL4278957 0.81 ALDH1A1 (0.60) ALDH1A1HSD17B10MAPK1MAPTHPGD
SCHEMBL4271695 0.80 GSK3B (0.45) ALDH1A1HSD17B10MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637559-B2 Oxazole compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-01-28 US disclosed
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221586-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION PDE3B, PDE4A, PDE3A ALDH1A1 234/4885HSD17B10 552/4885MAPK1 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.